Aurora Cannabis with ticker ACB was trading in an ABC correction through 2024 after a sharp and impulsive rally at the beginning of 2024. It actually formed a nice bullish setup formation at the ...

In a report released today, Bill Kirk from Roth MKM reiterated a Hold rating on Aurora Cannabis (ACB – Research Report), with a price target of C$8.00. The company’s shares closed yesterday at ...

Bevo Plant Propagation Revenue: $8.9 million, a 22% increase year-over-year. Consumer Cannabis Revenue: $9.9 million, down from $11.6 million last year. Aurora Cannabis Inc (NASDAQ:ACB) reported a ...

Investing.com -- Shares of Aurora Cannabis (TSX:ACB) Inc. (NASDAQ: NASDAQ:ACB) (TSX: ACB) soared 40% following the announcement of its fiscal 2025 third-quarter results. The Edmonton-based company ...

February 5, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas, including cannabis stocks reports on trading for Aurora Cannabis Inc. (TSX: ACB ...

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago.

Shares of Aurora Cannabis (NASDAQ:ACB) added ~27% in the premarket on Wednesday after the Canadian marijuana producer reported better-than-expected revenue for Q3 fiscal 2025, thanks mainly to its ...

(1) Working capital for the three months ended December 31, 2024 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A.

Aurora Cannabis swung to a profit in its fiscal third-quarter thanks rise in the estimated value of its biological assets and strong medical cannabis revenue. The Canadian cannabis company on ...